187733-13-7 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 3-aminothieno[3,2-c]pyridine-2-carboxylate is utilized as a building block for the synthesis of various biologically active compounds, particularly in the development of potential drug candidates. Its application is driven by its ability to contribute to the treatment of cancer, infectious diseases, and neurological disorders due to its unique structural features and reactivity.
Used in Materials Science:
In the field of materials science, Ethyl 3-aminothieno[3,2-c]pyridine-2-carboxylate is employed for its potential applications, leveraging its diverse reactivity and functional group compatibility. This allows for the creation of new materials with specific properties tailored for various applications.
Used in Organic Synthesis:
Ethyl 3-aminothieno[3,2-c]pyridine-2-carboxylate also serves as a key intermediate in organic synthesis, where its functional groups and reactivity are harnessed to produce a range of chemical products with different applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 187733-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,7,7,3 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 187733-13:
(8*1)+(7*8)+(6*7)+(5*7)+(4*3)+(3*3)+(2*1)+(1*3)=167
167 % 10 = 7
So 187733-13-7 is a valid CAS Registry Number.
187733-13-7Relevant academic research and scientific papers
Raf inhibitor compounds and methods of use thereof
-
Page/Page column 47, (2010/11/26)
Compounds of Formula I are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
